Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Search tool

Displaying 1 - 20 of 45

News

EMCDDA technical expert meeting on hexahydrocannabinol (HHC) and related cannabinoids

19.12.2022

On 16 December, the EMCDDA held the first ‘Technical expert meeting on hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSCs)’ as part of its ongoing work to support EU and national preparedness and response to emerging NPS risks. Hexahydrocannabinol is the first semi-synthetic

News

EMCDDA gets set for Lisbon Addictions 2022

22.11.2022

EMCDDA staff members will be among the 1 000 speakers gathering this week in Lisbon at the European Conference on Addictive Behaviours and Dependencies (Lisbon Addictions 2022).

News

Registration opens for European Drugs Winter and Summer Schools 2023

11.10.2022

The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) are delighted to open registration today for two upcoming joint events in 2023: the European Drugs Winter School (EDWS) and th

News

#WorldHepatitisDay — EMCDDA practical resources to help European countries beat viral hepatitis

28.07.2022

Every year, on 28 July, the World Health Organization (WHO) and partners commemorate World Hepatitis Day to increase awareness and understanding of viral hepatitis and the diseases it causes.

News

Monitoring drug use in the digital age: web surveys show ‘great promise’

29.06.2022

The online space has become increasingly relevant in identifying trends in illicit drug supply and demand. With increased internet activity globally, drug-related social interactions and purchases have also partially moved online.

News

EMCDDA launches foresight toolkit for the drugs field

23.06.2022

Analysing potential futures to support decision-making today is increasingly used in a world characterised by rapid, volatile and complex change. More and more organisations, including EU bodies (1), are integrating foresight approaches into their activities.

News

25 years of monitoring and responding to new drugs in Europe — update published today

14.06.2022

This year, the EU Early Warning System (EWS) on new psychoactive substances (NPS) celebrates its 25th anniversary.

News

What are the lessons to be learnt from the European Drug Report 2022?

14.06.2022

The European Drug Report 2022: Trends and Developments arrives at a time when recent major global events have impacted profoundly on all areas of our life and, therefore, also have implications for the drug problems w

News

25 years of early warning and response to new psychoactive substances in Europe

07.06.2022

This year, the EU Early Warning System (EWS) on new psychoactive substances (NPS) celebrates its 25th anniversary.

News

New explorer tool offers access to over 20 years of ESPAD data

25.05.2022

Today, the European School Survey Project on Alcohol and Other Drugs (ESPAD) is launching a new data explorer tool, allowing access to over 20 years of ESPAD data on substance use among 15-16-year-old students.

News

Coming soon: European Drug Report 2022 to be released on 14 June

20.05.2022

What do the latest data tell us about trends in drug use and the market? What hazardous new drugs are emerging? What substances are posing the greatest health threats?

News

Europe’s changing role in expanding cocaine and methamphetamine markets

06.05.2022

Europe’s role in international drug production and trade is changing, according to new analyses released today by the EU drugs agency (EMCDDA) and Europol (1).

News

Penalties for drug law offences in Europe ‘at a glance’ — new countries added to online tool

24.03.2022

How do countries’ laws deal with offences relating to drug use, possession for personal use or supply?

News

Latest wastewater data reveal drug-taking habits in 75 European cities in a record 25 countries — increases in detections of most drugs studied

17.03.2022

The 2021 findings from the largest European project in the science of wastewater analysis are revealed today in Wastewater analysis and drugs — a European multi-city study, published by the Europe-wid

News

Latest European Web Survey on Drugs finds cannabis and ecstasy use most impacted by COVID-19

20.01.2022

New survey results released today by the EU drugs agency (EMCDDA) reveal that cannabis and ecstasy use are the drug-consumption patterns most impacted by COVID-19 restrictions (1).

News

World AIDS Day: new EMCDDA miniguide on responding to drug-related infectious diseases

01.12.2021

Health and social responses to drug-related infectious diseases are explored today in a new EMCDDA miniguide, released to mark World AIDS Day.

News

Malta and Luxembourg announce plans for limited cultivation and use of cannabis

25.11.2021

On 4 October 2021 the equalities minister in Malta presented a bill to change laws on cannabis.

News

Lisbon Addictions is back! Registration and call for abstracts open today

25.10.2021

Leading international experts in the field of addiction science will gather in Lisbon from 23–25 November 2022 for the next European Conference on Addictive Behaviours and Dependencies (‘Lisbon Addictions 2022’).

News

Methamphetamine from Afghanistan: ‘signals indicate that Europe should be better prepared’, says new EMCDDA report

29.09.2021

This report was prepared before recent developments in Afghanistan and before the withdrawal of US military and other NATO allies from the country.

News

New report highlights public health and social risks posed by synthetic cannabinoids in Europe

09.09.2021

Synthetic cannabinoids come under the spotlight today in a new report released by the EU drugs agency (EMCDDA).
Loading